damnacanthal has been researched along with Leishmaniasis, Cutaneous in 1 studies
damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandjo, LP | 1 |
| de Moraes, MH | 1 |
| Kuete, V | 1 |
| Kamdoum, BC | 1 |
| Ngadjui, BT | 1 |
| Steindel, M | 1 |
1 other study available for damnacanthal and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Individual and combined antiparasitic effect of six plant metabolites against Leishmania amazonensis and Trypanosoma cruzi.
Topics: Alkaloids; Anthraquinones; Antiparasitic Agents; Antiprotozoal Agents; Chagas Disease; Chalcones; Fl | 2016 |